Evidence map›Paper›PMID 33947140›Full record

SynthesisGenes2021

Fibroblast Growth Factor 20 Gene Polymorphism in Parkinson's Disease in Asian Population: A Meta-Analysis.

Han-Lin Chiang, Yih-Ru Wu, Yi-Chun Chen, Hon-Chung Fung, Chiung-Mei Chen

Open access · goldAbstract readMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Quantitative assessment of the effect of FGF20 rs1721100 and rs12720208 variant on the risk of sporadic Parkinson's disease: a meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Han-Lin ChiangDepartment of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei 112, Taiwan.ORCID 0000-0002-0768-0059
Yih-Ru WuChang Gung Memorial Hospital Linkou Medical Center and College of Medicine, Department of Neurology, Chang Gung University, Taoyuan 333, Taiwan.
Yi-Chun ChenChang Gung Memorial Hospital Linkou Medical Center and College of Medicine, Department of Neurology, Chang Gung University, Taoyuan 333, Taiwan.ORCID 0000-0003-1115-2205
Hon-Chung FungFu Jen Faculty of Theology of St. Robert Bellarmine, Fu Jen University Clinic, Taipei 242, Taiwan.
Chiung-Mei ChenChang Gung Memorial Hospital Linkou Medical Center and College of Medicine, Department of Neurology, Chang Gung University, Taoyuan 333, Taiwan.ORCID 0000-0002-0769-0353
Chang Gung University · TWFu Jen Catholic University · TWTaipei Veterans General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a neurodegenerative disease with the pathological hallmark of Lewy bodies and Lewy neurites composed of α-synuclein. The SNP rs591323 is one of the risk loci located near the

Indexed as

Polymorphism, Single NucleotideChinaFibroblast Growth FactorsHumansParkinson DiseaseTaiwanFGF20 protein, humanFibroblast Growth FactorsFGF20fibroblast growth factor 20Parkinson’s diseasers591323

Identifiers

PMID33947140
PMCPMC8145858
OpenAlexW3157526635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.